Image credits: Pxfuel
/
Analysis

A Digital Offering for Health Companies

By Miriam Bello | Fri, 09/18/2020 - 17:24

Companies keeping up with technology and the digital transformation were the most likely to adapt best to COVID-19 challenges. This transformation can come in many forms and in health, the main trend has recently been telemedicine, along with AI, Big Data and blockchain, IoT, wearables and virtual reality.

Despite the benefits that technology can bring to health practices, its adoption in this sector has historically been slower in Mexico. According to Roberto Aguilera, Health Sciences & Wellness Consulting Partner at EY, this is due to doctors and other entities in the sector taking their time adapting to emerging changes. A report by Adobe shows that healthcare and pharmaceutical industries are far behind others in adapting these tools to their strategies. Only 7 percent of the companies in the sector have digitalized their practices, while the average is around 15 percent in other sectors. “Artificial intelligence is commonly used in service industries. However, in the health sector, it is very important to be sure that the information is true, which has been an obstacle for the adoption of digital tools,” explained Martha Gonzalez, Commercial Sales Director of Wirklich Wandel to MBN.  

Healthcare technology innovation has focused on creating more efficient and effective attention methods, treatments or diagnosis practices. For instance, with the greater use of smartphones, people are more aware of their physical activity or heart rate. The use of such devices has led many startups and companies to create mobile alternatives to their services.

Are doctors searching for telemedicine consultations? Yes, during an interview with Meddi’s Founders Pablo Aguirre and Roberto Riestra, MBN asked them about the common needs of doctors regarding technology, to which they highlighted three main points: digital clinical records, digital prescription methods and digital payment options.

Data plays a key role when working with pharmaceutical companies. “It is common to have sufficient data collected throughout the years across many projects and yet companies find themselves redoing many of the experiments because it is easier to redo the experiment than search through their own data pools,” said Gino Scarangella Sr. Director, Life Sciences NAM at Dassault Systèmes (DS), during an interview with MBN. Scarangella explained that these companies look forward to improving their R&D processes, leading DS to create a platform that connects applications to share data across different stages of the development process. “This allows companies to take advantage of data flows across the entire business to increase productivity and reduce the time from ideation to actual production.”

Virtual reality is a tool that has changed the game in the diagnosis sector. Medical devices companies, doctors and pharmaceutical companies can greatly benefit from products such as the Living Heart Project from DS that Scarangella also touched on during his interview with MBN. “Through this solution, companies can create a simulation of an individual’s heart and then look for positive treatments,” he said.

The value of these tools is slowly permeating Mexico and gradually, technology can ensure a correct diagnosis and follow-up on the patient. “Technology can predict the effectiveness of a treatment and at the same time determine the doses and duration of the treatment for each patient. In healthcare, time and cost can make a huge difference,” said Aguilera.

Photo by:   Pxfuel
Miriam Bello Miriam Bello Journalist and Industry Analyst